T he development of Foxp3 + regulatory T cells (T reg cells) in the thymus is dependent on signaling via the T cell antigen receptor (TCR) 1 , but the TCR's role in the function of T reg cells in the peri phery remains elusive. As acute ablation of T reg cells from the normal adult mouse results in the rapid development of a lethal auto immune syndrome 2 , it is likely that the suppressor function of T reg cells is constantly operative in vivo, yet evidence for TCR-mediated signaling in this process has been lacking. Levine et al. 3 now provide, for the first time, compelling data indicating that continuous expression of the TCR is required for T reg cell suppressor function in vivo.
The major tool used in this study is deletion of the TCR from peripheral T reg cells by administration of tamoxifen to adult mice carrying Foxp3 eGFP-Cre-ERT2 (a fusion expressing enhanced green fluorescent protein, Cre recombinase and the estrogen receptor ligand-binding domain protein) that have been crossed to Trac FL/WT or Trac FL/FL mice, in which one or both alleles of Tcra, specifically the gene segment (Trac) encoding the constant region of the TCR α-chain, were flanked by two loxP sites. A minor population (~20%) of TCR-deficient T reg cells was generated in the heterozygous cross, whereas in mice descended from the homozygous cross the majority (~70%) of T reg cells lacked the TCR. In addition, the authors bred Trac FL/FL mice to Foxp3 YFP-Cre mice to induce TCR deletion in newly generated T reg cells. In all of these models, most of the T reg cells that lacked the TCR expressed normal amounts of Foxp3 as well as other T reg signature molecules such as CD25, GITR, CD39 and CD73. However, CTLA-4 expression is induced by TCR signaling, as T reg cells with TCR ablation induced by Foxp3 YFP-Cre failed to upregulate CTLA-4.
TCR signaling fuels T reg cell suppressor function
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Acute ablation of T cell antigen receptors (TCRs) in regulatory T cells (T reg cells) impairs the suppressive activity of these cells, even though they retain expression of Foxp3 and CD25. TCR signaling imparts a critical role in the suppressive function of T reg cells.
Both Ctla4 mRNA and CTLA-4 protein were also reduced when the Tcra gene was deleted by Foxp3 eGFP-Cre-ERT2 after tamoxifen treatment, indicating that CTLA-4 expression in T reg cells requires continuous TCR signaling. No evidence that loss of the TCR resulted in loss of Foxp3 expression was seen in fatemapping studies.
The authors also report that just as in the conventional CD4 + T cell compartment, T reg cells consist of CD44 lo CD62L hi 'naivelike' and CD44 hi CD62L lo 'effector-like' populations. The most striking finding in this study was that the total numbers of TCRnegative T reg cells in the two inducible deletion models (Foxp3 eGFP-Cre-ERT2 Trac FL/WT and Foxp3 eGFP-Cre-ERT2 Trac FL/FL , of which only the latter resulted in autoimmunity) were essentially normal, but ablation of the TCR resulted in a marked loss of the T reg 'effector-like' cell population. On the other hand, Foxp3 YFP-Cremediated deletion of Tcra prevented the generation of CD44 hi CD62L lo 'effector-like' T reg cells. This finding was also correlated with decreased proliferation and severe reduction in cell numbers of the TCR-negative T reg cell population. These results are most consistent with the requirement of a TCR signal for the differentiation as well as maintenance of T reg 'effector-like' cells ( Fig. 1) 3 . Within the 'effector-like' T reg cell subset, 155 genes were significantly downregulated in the absence of the TCR, including those encoding transcription factors (NFATc1, c-Rel, IRF4 and Bcl-6) and inhibitory molecules (CD83, CD200, LAG-3, IL-10 and EBI3). Levine et al. raise the possibility that IRF4 has a critical role in T reg 'effector-like' cell differentiation downstream from TCR signals 3 . The transcription factor IRF4 is also highly upregulated by TCR stimulation in effector T cells. In fact, IRF4 plays a critical role in the differentiation of T H 2, T H 17 and follicular helper T cells (T FH cells) through its interaction with members of the BATF protein family 5 . In T reg cells, IRF4 interacts with Foxp3 and regulates ~20% of 'T reg cell-specific' genes, and specific deletion of Irf4 in T reg cells by Foxp3-Cre results in severe autoimmune lymphoproliferative diseases with uncontrolled T H 2 responses 6 . IRF4 affects the expression of IL-10, ICOS and CCR8, but not CD25, GITR and CLTA-4. However, in the current study inducible deletion of Irf4 in mature T reg cells produced only a very modest effect. Although this small effect size may have resulted from inefficient ablation of IRF4, it is also possible that IRF4 may not be very critical for maintaining the activation status of T reg cells. To fully determine the contribution of an IRF4-mediated positive feedforward regulatory loop in the activation of T reg cells by the TCR, it is necessary to compare the genes regulated by IRF4 with those regulated by TCR activation. Interestingly, the genes that depend on continuous TCR signaling for their expression are largely regulated by Foxp3. Although Foxp3 by itself is not sufficient to induce and/or maintain the expression of these TCR-inducible genes, Foxp3 is needed to collaborate with TCR signaling to promote gene expression in 'effector-like' T reg cells.
Several questions raised by this work merit further investigation. Although it is clear from this study that TCR activation is required for the generation of 'effectorlike' T reg cells with suppressor function and nature immunology volume 15 number 11 november 2014 their suppressive function in vivo. For example, would blocking the TCR specifically on T reg cells (if possible) impair their function and represent an adjunct to tumor therapy? At present, low-dose IL-2 therapy has been advocated as a potentially safe, effective approach to augmenting T reg cell function in a variety of experimental studies and human clinical trials 9 . Yet the target of low-dose IL-2 would be the nonsuppressive CD44 lo CD62L hi population that expresses large amounts of CD25 (ref. 10) . Do the beneficial effects of this therapy depend on simultaneous TCR activation and differentiation of the CD44 lo CD62L hi T reg cells to 'suppressor effector-like' CD44 hi CD62L lo T reg cells? The failure of IL-2 immune complexes to reverse the activation of conventional CD4 + T cells in the present study suggests that this is unlikely to be the mechanism. Conversely, how can we directly augment the numbers and function of the CD44 hi CD62L lo 'effector-like' T reg cells? Smigiel et al. suggest that their maintenance depends of ICOS-ICOSL signaling 10 , but this pathway does not appear to mediate their proliferation, as inhibition of ICOS signaling did not reduce the cycling of the CD44 hi CD62L lo T reg cells. Lastly, one potential alternative approach for the expansion of 'effector-like' T reg cells may be the delivery of costimulation in the absence of an overt TCR signal-for example, the delivery of CD28-mediated costimulation with a CD28 superagonist monoclonal antibody 11 . It remains to be determined whether this type of stimulation would selectively expand CD44 hi CD62L lo T reg cells. periphery, inducing suppressive activity. It will be important to determine whether T reg cells activated in the thymus already express suppression-related genes or whether these genes need to be induced in the periphery by TCR stimulation.
Studies performed in vitro have suggested that the suppressor function of T reg cells requires TCR activation but that, once activated, suppressor function is nonspecific 8 . Does a similar situation exist in vivo? It also remains unclear whether upon TCR activation, CD44 lo CD62L hi 'naive-like' T reg cells can turn into CD44 hi CD62L lo 'effector-like' T reg cells. In the future, it will be important to understand the dynamics between these two states. What is the rate of such transition at steady state? Are the TCR repertoires of these two populations the same, or is the CD44 hi CD62L lo 'effector-like' population more self-reactive? Can CD44 hi CD62L low 'effector-like' T reg cells revert to CD44 lo CD62L hi 'naive-like' T reg cells or are they terminally differentiated?
An additional issue raised by these studies is how the results might influence the design of therapies to maximize the abundance of T reg cells or, more importantly, that CD44 hi T reg cells with TCR ablation have changed their gene expression pattern, the requirements for TCR signaling for the maintenance of the CD44 hi CD62L lo T reg cell population in vivo remain to be further elucidated. Approximately 50% of this subpopulation cycles every 2-3 days in vivo, as measured by Ki67 staining. Yet it is unknown whether TCR-derived signals play any role in this process, which must also include the death of a major proportion of the cycling cells, as absolute numbers of T reg cells remain constant for the life of the animal. In this regard, the cycling of T reg cells in vivo closely resembles the cycling of conventional memory phenotype CD44 hi CD4 + T cells 7 , and the factors that regulate the proliferation of CD44 hi CD4 + T cells also remain to be fully characterized. Normal adult thymus does contain a population of CD44 hi T reg cells that cycle at a frequency slightly less than that of CD44 hi T reg cells in the periphery (M. Holt and E.M.S., unpublished observations). It is thus possible that there are two waves of TCRinduced activation of T reg cells, with the first wave, in the thymus, resulting in partial T cell activation and the second wave, in the 
